-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VAYxINj9aakqnECujBMWDsqHZ3YU0t+7MScKroVSyuqn/ghtoZoLC2jyhhIEw9C7 AYCsKKqsZdoRf6AY9NF4Pw== 0001225208-10-014911.txt : 20100609 0001225208-10-014911.hdr.sgml : 20100609 20100609160242 ACCESSION NUMBER: 0001225208-10-014911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100607 FILED AS OF DATE: 20100609 DATE AS OF CHANGE: 20100609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABELE JOHN E CENTRAL INDEX KEY: 0000901430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 10887277 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 4 1 doc4.xml X0303 4 2010-06-07 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901430 ABELE JOHN E ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2010-06-07 4 S 0 25000 5.6489 D 3341949 I By LLC Common Stock 2010-06-07 4 S 0 50000 5.6469 D 3291949 I By LLC Common Stock 13162718 D Common Stock 400000 I By Spouse Common Stock 351098 I By Trust Sales reported on this form were transacted pursuant to a 10b5-1 trading plan. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $5.68 to $5.59. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. Common stock held by a limited liability company of which reporting person holds 100% membership interest. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $5.77 to $5.57. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. Common stock held by the reporting person's wife. The reporting person disclaims beneficial ownership of these shares. Common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares. poaabele2010.TXT /s/ Ann C. Brachman, Attorney-in-Fact 2010-06-09 EX-24 2 poaabele2010.txt POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Timothy A. Pratt, Vance R. Brown, Anne M. Thompson, Michelle K. Gewandter and Nancy W. Glasheen, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; (3) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of the Company, Forms 144 in accordance with Rule 144 of the Securities Exchange Act of 1933, as amended and the rules and regulations thereunder; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power And authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the Securities Act of 1933, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 8th day of June, 2010. /s/ John E. Abele John E. Abele -----END PRIVACY-ENHANCED MESSAGE-----